Product Program year 2025 Source: CMS Open Payments

Selectra

Device Cardiology/Vascular Diseases

PDI 07640130455405

Open in the dashboard

General payments

$328,232

1,300 payments

Research payments

$0

0 payments

Through program year 2025, $328,232 in general payments and $0 in research payments were reported against Selectra (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $52,470 494
2024 General $249,532 568
2023 General $26,230 238

Breakdown

Who paid General payments · program years 2023–2025
  1. Biotronik Inc. $328,232 1,300 payments
Top recipients General payments · program year 2025
  1. Gregory Harris Clinical Cardiac Electrophysiology · Greenville, NC $15,649 30% · 12 payments
  2. David Schleinkofer Clinical Cardiac Electrophysiology · Fort Wayne, IN $1,290 2% · 2 payments
  3. Matthew Levy Clinical Cardiac Electrophysiology · San Jose, CA $1,228 2% · 5 payments
  4. Sunil Kapur Cardiovascular Disease · Boston, MA $1,155 2% · 4 payments
  5. Alexander Ochman Interventional Cardiology · Bend, OR $1,084 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $35,018 68% · 114 practitioners
  2. Cardiovascular Disease Internal Medicine $10,105 20% · 88 practitioners
  3. Interventional Cardiology Internal Medicine $3,575 7% · 24 practitioners
  4. Internal Medicine $925 2% · 12 practitioners
  5. Nurse Practitioner, Acute Care Nurse Practitioner $461 <1% · 6 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $16,663 32% · 19 recipients
  2. California $6,173 12% · 50 recipients
  3. Florida $3,535 7% · 33 recipients
  4. Michigan $3,342 6% · 15 recipients
  5. New York $3,030 6% · 18 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,300 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record